These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28884610)

  • 1. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
    Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
    Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
    J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
    Grilz E; Posch F; Königsbrügge O; Schwarzinger I; Lang IM; Marosi C; Pabinger I; Ay C
    Thromb Haemost; 2018 Nov; 118(11):1875-1884. PubMed ID: 30296815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
    Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
    Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-Lymphocyte Ratio is a Predictor of Venous Thromboembolism in Gastric Cancer Patients.
    Du P
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
    Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
    Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
    Yang W; Liu Y
    Thromb Res; 2015 Aug; 136(2):212-5. PubMed ID: 25533129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
    Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
    Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
    JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism Risk in Head and Neck Cancer: Significance of the Preoperative Platelet-to-Lymphocyte Ratio.
    Tham T; Rahman L; Persaud C; Olson C; Costantino P
    Otolaryngol Head Neck Surg; 2018 Jul; 159(1):85-91. PubMed ID: 29406795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study.
    Douce DR; Holmes CE; Cushman M; MacLean CD; Ades S; Zakai NA
    J Thromb Haemost; 2019 Dec; 17(12):2152-2159. PubMed ID: 31423717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.
    Artoni A; Abbattista M; Bucciarelli P; Gianniello F; Scalambrino E; Pappalardo E; Peyvandi F; Martinelli I
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):808-814. PubMed ID: 29088921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Umaña-Mora C; Céspedes-Calvo A; Mora-Hidalgo R
    Ecancermedicalscience; 2022; 16():1470. PubMed ID: 36819798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison among three predictive models for cancer-associated thromboembolism in a hispanic population.
    Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Céspedes-Calvo A; Mora-Hidalgo R
    J Thromb Thrombolysis; 2023 Oct; 56(3):433-438. PubMed ID: 37407771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.